NeurosciencebioRxivPreprint
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects
Ryan Cantwell Chater, Julian Peiser-Oliver, Tanmay K. Pati…·Azadeh Shahsavar
This paper develops a reversible GlyT2 inhibitor that alleviates neuropathic pain without on-target side effects or addiction liability.
1 citation